4//SEC Filing
Myers Thomas Richard 4
Accession 0001209191-21-042595
CIK 0001006028other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 8:25 PM ET
Size
8.1 KB
Accession
0001209191-21-042595
Insider Transaction Report
Form 4
Myers Thomas Richard
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-06-18+100,000→ 100,000 totalExercise: $0.45Exp: 2031-06-18→ Common Stock (100,000 underlying) - Award
Stock Option (Right to Buy)
2021-06-18+125,000→ 125,000 totalExercise: $0.45Exp: 2031-06-18→ Common Stock (125,000 underlying)
Footnotes (2)
- [F1]The option shares shall vest and become exercisable as follows: (i) 50% of the option will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2022 or January 15, 2022 and (ii) 50% of the options will vest on the earlier of the date of the Issuer's annual meeting of stockholders held in 2023 or January 15, 2023.
- [F2]The option shares shall vest and become exercisable in four equal installments on September 18, 2021, December 18, 2021, March 18, 2022 and June 18, 2022.
Documents
Issuer
PURE BIOSCIENCE, INC.
CIK 0001006028
Entity typeother
Related Parties
1- filerCIK 0001755512
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 8:25 PM ET
- Size
- 8.1 KB